Siddiqui, M.S.; Francois, M.; Rainey-Smith, S.; Martins, R.; Masters, C.L.; Ames, D.; Rowe, C.C.; Macaulay, L.S.; Fenech, M.F.; Leifert, W.R.
Evaluation of GammaH2AX in Buccal Cells as a Molecular Biomarker of DNA Damage in Alzheimer’s Disease in the AIBL Study of Ageing. Life 2020, 10, 141.
https://doi.org/10.3390/life10080141
AMA Style
Siddiqui MS, Francois M, Rainey-Smith S, Martins R, Masters CL, Ames D, Rowe CC, Macaulay LS, Fenech MF, Leifert WR.
Evaluation of GammaH2AX in Buccal Cells as a Molecular Biomarker of DNA Damage in Alzheimer’s Disease in the AIBL Study of Ageing. Life. 2020; 10(8):141.
https://doi.org/10.3390/life10080141
Chicago/Turabian Style
Siddiqui, Mohammad Sabbir, Maxime Francois, Stephanie Rainey-Smith, Ralph Martins, Colin L. Masters, David Ames, Christopher C. Rowe, Lance S. Macaulay, Michael F. Fenech, and Wayne R. Leifert.
2020. "Evaluation of GammaH2AX in Buccal Cells as a Molecular Biomarker of DNA Damage in Alzheimer’s Disease in the AIBL Study of Ageing" Life 10, no. 8: 141.
https://doi.org/10.3390/life10080141
APA Style
Siddiqui, M. S., Francois, M., Rainey-Smith, S., Martins, R., Masters, C. L., Ames, D., Rowe, C. C., Macaulay, L. S., Fenech, M. F., & Leifert, W. R.
(2020). Evaluation of GammaH2AX in Buccal Cells as a Molecular Biomarker of DNA Damage in Alzheimer’s Disease in the AIBL Study of Ageing. Life, 10(8), 141.
https://doi.org/10.3390/life10080141